Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for ocular surface squamous neoplasia has been reported in the published literature.
2 clinical trials registered, 2 recruiting. Interventions under study include procedural interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
130 publications have been identified in PubMed for ocular surface squamous neoplasia. Research spans Case Report / Case Series (28%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 37 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 2:13 PM UTC
European rare disease database
Research summaries | 32 | 25% |
Testing and diagnosis research | 18 | 14% |
Clinical study results | 18 | 14% |
Disease patterns and progression | 14 | 11% |
Laboratory research | 6 | 5% |
New treatment approaches | 4 | 3% |
Other research | 1 | 1% |
Ramachandran RG (2026). [PMID: 42165725](https://pubmed.ncbi.nlm.nih.gov/42165725/). *Indian J Med Res*. [Basic Science / Preclinical]
Daryabari SH (2026). [PMID: 42047870](https://pubmed.ncbi.nlm.nih.gov/42047870/). *Int Ophthalmol*. [Review / Meta-Analysis]
Ghanbari H (2026). [PMID: 41284036](https://pubmed.ncbi.nlm.nih.gov/41284036/). *Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie*. [Clinical Trial Publication]
Mhlongo LN (2026). [PMID: 41791292](https://pubmed.ncbi.nlm.nih.gov/41791292/). *Experimental eye research*. [Diagnostic / Biomarker]
Li WJ (2026). [PMID: 41705454](https://pubmed.ncbi.nlm.nih.gov/41705454/). *Clinical & experimental ophthalmology*. [Review / Meta-Analysis]
Höllhumer R (2026). [PMID: 41857333](https://pubmed.ncbi.nlm.nih.gov/41857333/). *Eye (London, England)*. [Case Report / Case Series]
Serbest Ceylanoglu K (2026). [PMID: 41518381](https://pubmed.ncbi.nlm.nih.gov/41518381/). *Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie*. [Diagnostic / Biomarker]
Mercado C (2026). [PMID: 41549989](https://pubmed.ncbi.nlm.nih.gov/41549989/). *Seminars in ophthalmology*. [Review / Meta-Analysis]
Wong QY (2026). [PMID: 41899324](https://pubmed.ncbi.nlm.nih.gov/41899324/). *Journal of clinical medicine*. [Review / Meta-Analysis]
Yang YC (2026). [PMID: 40690989](https://pubmed.ncbi.nlm.nih.gov/40690989/). *Clinical & experimental optometry*. [Clinical Trial Publication]
AI-curated news mentioning ocular surface squamous neoplasia
Updated Jun 4, 2026
A nonrandomized clinical trial demonstrates the feasibility of smartphone-based proactive self-screening for ocular surface malignancies. This innovative approach could enhance early detection and patient engagement in managing their ocular health.
A new deep learning-based diagnostic model has been developed for ocular surface neoplastic diseases, potentially improving early detection and treatment outcomes. This research highlights advancements in AI applications within rare disease diagnostics.